INSIGHTS ON CLINICAL TRIAL PARTNERING

• Advantages Of Sourcing Biosimilars Vs. Branded Biologics In Clinical Trials

  Evaluate biosimilar alternatives during clinical trial planning to reduce comparator drug costs and improve overall study efficiency without compromising trial integrity.

• Designed To Help Sites Increase Clinical Trial Capacity

  IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.

• Bringing Clinical Trials To Everyone's Backyard

  Learn how bringing clinical trials to any community around the world is not only possible but also increases patient access and reach and improves recruitment and retention.

• Overcoming Unexpected Obstacles In A Phase 1 Study

  Discover how the implementation of mobile vision clinics (MVCs) was used to enhance efficiency in a Phase 1 clinical trial.

• Early Phase Oncology Site Network: Benefits Of A Personal Touch

  11/17/2025

  Choose a site network built on partnership — not volume — to drive smoother early-phase oncology trials and deliver better outcomes for sponsors, sites, and patients.

• Building A Gold Standard Trial Experience In Japan

  4/4/2025

  Hear how Medable worked with a Japanese sponsor to elevate their trial experience, achieve >90% patient and site adherence, and beat their forecasted FPI date, creating new eCOA standards adopted across all the customer’s vendors.

• Open-Label Study Assessing Relative And Absolute Bioavailability

  1/26/2026

  Consistent absorption across different formulations and dietary conditions ensures stable therapeutic exposure. This flexibility simplifies patient dosing schedules and supports manufacturing transitions.

• Harnessing AI for Pre-Award Landscape Analysis And Site Selection

  1/16/2026

  AI-driven insights transform site selection and feasibility, enabling faster decisions and reducing risk. Predictive modeling and real-time data improve pre-award planning and trial outcomes.

• Advancing Ovarian Cancer Therapies: Clinical Research Trends, Challenges, And Proven Strategies

  8/29/2025

  Ovarian cancer remains one of the deadliest gynecologic malignancies. Successful clinical trials in this space demand deep therapeutic expertise, operational agility, and global coordination.